Publications

David Hodgson , J. Hay , S. Jarju , D. Jobe , R. Wenlock , et al.
In *PLOS Computational Biology*
In *PLOS Comput Biol*
A Bayesian tool for inferring infection timing and antibody kinetics from longitudinal serological data, validated with SARS-CoV-2 data from The Gambia.
Code Project DOI Full Text

David Hodgson , Yi Liu , Louise Carolan , Siddhartha Mahanty , Kanta Subbarao , Sheena G. Sullivan , Annette Fox , Adam Kucharski
In *Frontiers Immunology*
In *Frontiers Immunology*
This study compares immune responses between ChAdOx1 (Adenovirus-based) and BNT162b2 (mRNA) COVID-19 vaccines. It finds that mRNA vaccines induce significantly higher memory B cell proliferation and longer-lasting antibody responses than Adenovirus vaccines, especially with extended dosing intervals.
Code Project DOI Full Text

David Hodgson , Stephany Sánchez-Ovando , Louise Carolan , Yi Liu , A. Jessica Hadiprodjo , Annette Fox , Sheena G. Sullivan , Adam J. Kucharski
In *Vaccine*
In *Vaccine*
This study explores how pre-vaccination HAI titres and vaccination history influence post-vaccine antibody responses in influenza vaccines. It finds that individuals with lower pre-vaccine antibody levels experience a larger and longer-lasting antibody boost after vaccination, while frequent vaccine recipients show a diminished response. The study emphasizes the importance of considering individual pre-vaccine antibody levels and vaccine history when interpreting post-vaccination antibody dynamics.
Code Project DOI Full Text

David Hodgson , Neil Wilkins , Edwin van Leeuwen , Conall H. Watson , Jonathan Crofts , Stefan Flasche , Mark Jit , Katherine E. Atkins
In *Lancet Europe*
In *Lancet Europe*
This study compares the cost-effectiveness of long-acting monoclonal antibodies and maternal vaccines for RSV prevention in young children.
Code Project DOI Full Text

David Hodgson , Richard Pebody , Jasmina Panovska-Griffiths , Marc Baguelin , Katherine E. Atkins
In *Journal of Infectious Disease Modelling*
In *JIDM*
This study evaluates new RSV intervention strategies using mathematical modelling and economic analysis, highlighting the cost-effectiveness of seasonal programmes.
PDF Code Project DOI Full Text

David Hodgson , Mihaly Koltai , Fabienne Krauer , Stefan Flasche , Mark Jit , Katherine E. Atkins
In *Vaccine*
In *Vaccine*
This study evaluates the cost-effectiveness of Nirsevimab intervention programmes for RSV prevention in England and Wales.
Code Project DOI Full Text

Hayley Colton , David Hodgson , Hailey Hornsby , Rebecca Brown , Joanne Mckenzie , Kirsty L. Bradley , Cameron James , Benjamin B. Lindsey , Sarah Birch , Louise Marsh , Steven Wood , Martin Bayley , Gary Dickson , David C. James , Martin J. Nicklin , Jon R. Sayers , Domen Zafred , Sarah L. Rowland-Jones , Goura Kudesia , Adam Kucharski , Thomas C. Darton , Thushan I. de Silva , Paul J. Collini
In *PMC*
In *PMC*
This study measures SARS-CoV-2 seroprevalence among UK healthcare workers following the first COVID-19 pandemic wave and explores risk factors and assay sensitivity.
PDF Code Project DOI Full Text

David Hodgson , Marc Baguelin , Edwin van Leeuwen , Jasmina Panovska-Griffiths , Mary Ramsay , Richard Pebody , Katherine E. Atkins
In *The Lancet Public Health*
In *Lancet Public Health*
This study evaluates the epidemiological and cost-effectiveness impacts of mass paediatric influenza vaccination on existing elderly and risk-group programmes in England and Wales.
PDF Project DOI DOI